Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer Article

cited authors

  • Sharma, Neelesh; Pennell, Nathan; Nickolich, Myles; Halmos, Balazs; Ma, Patrick; Mekhail, Tarek; Fu, Pingfu; Dowlati, Afshin

authors

Publication Date

  • April 1, 2014

webpage

published in

category

keywords

  • Angiogenesis inhibitor
  • Small cell lung cancer
  • Sorafenib
  • VEGFR tyrosine kinase inhibitor

start page

  • 362

end page

  • 368

volume

  • 32

issue

  • 2